New Key Statistics Module, Z-Score and F-Score
SHSE:603963 Key Ratios
Market Cap ¥ M | 586.60 |
Enterprise Value ¥ M | 366.30 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.56 |
Price/Sales | 9.03 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 65.00 |
EPS (TTM) ¥ | -0.10 |
Beneish M-Score | -2.72 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -19.06 |
EV-to-EBITDA | -19.06 |
PEG | -- |
Shares Outstanding M | 219.70 |
Net Margin (%) | -34.79 |
Operating Margin % | -41.69 |
Pre-tax Margin (%) | -31.47 |
Quick Ratio | 3.11 |
Current Ratio | 3.98 |
ROA % (ttm) | -4.85 |
ROE % (ttm) | -5.92 |
ROIC % (ttm) | -14.54 |
Dividend Yield % | -- |
Altman Z-Score | 4.38 |
SHSE:603963 Number of Guru Trades
SHSE:603963 Volume of Guru Trades
Gurus Latest Trades with SHSE:603963
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603963 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Dali Pharmaceutical Co Ltd Insider Transactions
No Available Data